The association of anti‐platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery
Ian J. Welsby(Durham VA Health Care System), Thomas L. Ortel(Duke University), Ishwori Dhakal(Duke University), Gowthami M. Arepally(Duke Medical Center), Emily C. Williams, Shahar Bar-Yosef(Durham VA Medical Center), Elizabeth F. Krakow(Fred Hutch Cancer Center), J. Krischer(University of South Florida), Wei Wei Liu(Academy of Military Medical Sciences), Susan M. Martinelli, David F. Kong(Clinical Research Institute), John A. Heit(Mayo Clinic)
Cited by 26
Related Papers
Prevention of VTE in Nonorthopedic Surgical Patients
|CHEST Journal|2012|2.1k
Prevention of VTE in Orthopedic Surgery Patients
|CHEST Journal|2012|1.9k
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
|Regional Anesthesia & Pain Medicine|2009|1.5k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
|New England Journal of Medicine|2015|1.2k